Literature DB >> 24789877

MYC regulation of cell growth through control of transcription by RNA polymerases I and III.

Kirsteen J Campbell1, Robert J White.   

Abstract

MYC's tumorigenic potential involves increased ribosome biogenesis and translational capacity, which supply the cell with protein required for enhanced cell growth and subsequent cell division. In addition to activation of protein-encoding genes transcribed by RNA polymerase II, MYC must stimulate transcription by RNA polymerase I and RNA polymerase III to meet this synthetic demand. In the past decade our knowledge of the mechanisms and importance of MYC regulation of RNA polymerases I and III has flourished. Here we discuss MYC's influence on transcription by these "odd" RNA polymerases and the physiological impact of this regulation is evaluated with relevance to cancer development and treatment.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789877      PMCID: PMC3996375          DOI: 10.1101/cshperspect.a018408

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  49 in total

Review 1.  Recruitment of RNA polymerase III to its target promoters.

Authors:  Laura Schramm; Nouria Hernandez
Journal:  Genes Dev       Date:  2002-10-15       Impact factor: 11.361

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

3.  A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis.

Authors:  Jessica D Kessler; Kristopher T Kahle; Tingting Sun; Kristen L Meerbrey; Michael R Schlabach; Earlene M Schmitt; Samuel O Skinner; Qikai Xu; Mamie Z Li; Zachary C Hartman; Mitchell Rao; Peng Yu; Rocio Dominguez-Vidana; Anthony C Liang; Nicole L Solimini; Ronald J Bernardi; Bing Yu; Tiffany Hsu; Ido Golding; Ji Luo; C Kent Osborne; Chad J Creighton; Susan G Hilsenbeck; Rachel Schiff; Chad A Shaw; Stephen J Elledge; Thomas F Westbrook
Journal:  Science       Date:  2011-12-08       Impact factor: 47.728

4.  Epstein-Barr virus-encoded EBNA1 enhances RNA polymerase III-dependent EBER expression through induction of EBER-associated cellular transcription factors.

Authors:  Thomas J Owen; John D O'Neil; Christopher W Dawson; Chunfang Hu; Xiaoyi Chen; Yunhong Yao; Victoria H J Wood; Louise E Mitchell; Robert J White; Lawrence S Young; John R Arrand
Journal:  Mol Cancer       Date:  2010-09-15       Impact factor: 27.401

5.  Regulation of RNA polymerase III transcription during hypertrophic growth.

Authors:  Sarah J Goodfellow; Fiona Innes; Louise E Derblay; W Robb MacLellan; Pamela H Scott; Robert J White
Journal:  EMBO J       Date:  2006-03-16       Impact factor: 11.598

6.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

7.  TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription.

Authors:  Niall S Kenneth; Ben A Ramsbottom; Natividad Gomez-Roman; Lynne Marshall; Philip A Cole; Robert J White
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-11       Impact factor: 11.205

8.  c-MYC coordinately regulates ribosomal gene chromatin remodeling and Pol I availability during granulocyte differentiation.

Authors:  Gretchen Poortinga; Meaghan Wall; Elaine Sanij; Kasia Siwicki; Jason Ellul; Daniel Brown; Timothy P Holloway; Ross D Hannan; Grant A McArthur
Journal:  Nucleic Acids Res       Date:  2010-12-21       Impact factor: 16.971

9.  Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency.

Authors:  Maria Barna; Aya Pusic; Ornella Zollo; Maria Costa; Nadya Kondrashov; Eduardo Rego; Pulivarthi H Rao; Davide Ruggero
Journal:  Nature       Date:  2008-11-16       Impact factor: 49.962

10.  The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells.

Authors:  A W Harris; C A Pinkert; M Crawford; W Y Langdon; R L Brinster; J M Adams
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  39 in total

1.  Expression of Muscle-Specific Ribosomal Protein L3-Like Impairs Myotube Growth.

Authors:  Thomas Chaillou; Xiping Zhang; John J McCarthy
Journal:  J Cell Physiol       Date:  2016-01-14       Impact factor: 6.384

Review 2.  An overview of MYC and its interactome.

Authors:  Maralice Conacci-Sorrell; Lisa McFerrin; Robert N Eisenman
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

3.  Coordinated Activities of Multiple Myc-dependent and Myc-independent Biosynthetic Pathways in Hepatoblastoma.

Authors:  Huabo Wang; Jie Lu; Lia R Edmunds; Sucheta Kulkarni; James Dolezal; Junyan Tao; Sarangarajan Ranganathan; Laura Jackson; Marc Fromherz; Donna Beer-Stolz; Radha Uppala; Sivakama Bharathi; Satdarshan P Monga; Eric S Goetzman; Edward V Prochownik
Journal:  J Biol Chem       Date:  2016-10-13       Impact factor: 5.157

4.  Differential phosphorylation of a regulatory subunit of protein kinase CK2 by target of rapamycin complex 1 signaling and the Cdc-like kinase Kns1.

Authors:  Manuel E Sanchez-Casalongue; Jaehoon Lee; Aviva Diamond; Scott Shuldiner; Robyn D Moir; Ian M Willis
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

5.  Synergistic antileukemic therapies in NOTCH1-induced T-ALL.

Authors:  Marta Sanchez-Martin; Alberto Ambesi-Impiombato; Yue Qin; Daniel Herranz; Mukesh Bansal; Tiziana Girardi; Elisabeth Paietta; Martin S Tallman; Jacob M Rowe; Kim De Keersmaecker; Andrea Califano; Adolfo A Ferrando
Journal:  Proc Natl Acad Sci U S A       Date:  2017-02-07       Impact factor: 11.205

Review 6.  MYC protein interactors in gene transcription and cancer.

Authors:  Diana Resetca; Cornelia Redel; Corey Lourenco; Peter Lin; Alannah S MacDonald; Roberto Ciaccio; Tristan M G Kenney; Yong Wei; David W Andrews; Maria Sunnerhagen; Cheryl H Arrowsmith; Brian Raught; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2021-06-29       Impact factor: 60.716

Review 7.  MYC and the control of DNA replication.

Authors:  David Dominguez-Sola; Jean Gautier
Journal:  Cold Spring Harb Perspect Med       Date:  2014-06-02       Impact factor: 6.915

Review 8.  Synthetic lethal screens as a means to understand and treat MYC-driven cancers.

Authors:  Silvia Cermelli; In Sock Jang; Brady Bernard; Carla Grandori
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

Review 9.  The Target of Rapamycin Signalling Pathway in Ageing and Lifespan Regulation.

Authors:  Ivana Bjedov; Charalampos Rallis
Journal:  Genes (Basel)       Date:  2020-09-03       Impact factor: 4.096

Review 10.  Socializing with MYC: cell competition in development and as a model for premalignant cancer.

Authors:  Laura A Johnston
Journal:  Cold Spring Harb Perspect Med       Date:  2014-04-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.